Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-034121
Filing Date
2024-08-01
Accepted
2024-08-01 16:05:38
Documents
82
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20240630.htm   iXBRL 10-Q 1624154
2 EX-10.1 exhibit101-xardelyxxamende.htm EX-10.1 239234
3 EX-10.2 exhibit102-xardelyxxamende.htm EX-10.2 111022
4 EX-31.1 ardx-20240630xex311.htm EX-31.1 9756
5 EX-31.2 ardx-20240630xex312.htm EX-31.2 9778
6 EX-32.1 ardx-20240630xex321.htm EX-32.1 6457
12 ardx-20240630_g1.jpg GRAPHIC 75659
  Complete submission text file 0001628280-24-034121.txt   8174925

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20240630.xsd EX-101.SCH 57783
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20240630_cal.xml EX-101.CAL 67882
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20240630_def.xml EX-101.DEF 231848
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20240630_lab.xml EX-101.LAB 675388
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20240630_pre.xml EX-101.PRE 450273
85 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20240630_htm.xml XML 1023507
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 241166551
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)